BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21270633)

  • 1. The value of lesser-impact-factor surgical journals as a source of negative and inconclusive outcomes reporting.
    Kanaan Z; Galandiuk S; Abby M; Shannon KV; Dajani D; Hicks N; Rai SN
    Ann Surg; 2011 Mar; 253(3):619-23. PubMed ID: 21270633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funding source and conflict of interest disclosures by authors and editors in gastroenterology specialty journals.
    Bhargava N; Qureshi J; Vakil N
    Am J Gastroenterol; 2007 Jun; 102(6):1146-50. PubMed ID: 17531007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common standard for conflict of interest disclosure in addiction journals.
    Goozner M; Caplan A; Moreno J; Kramer BS; Babor TF; Husser WC
    Addiction; 2009 Nov; 104(11):1779-84. PubMed ID: 19832777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature.
    Khan SN; Mermer MJ; Myers E; Sandhu HS
    Am J Orthop (Belle Mead NJ); 2008 Dec; 37(12):E205-12; discussion E212. PubMed ID: 19212579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research.
    Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA
    Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial policy and the reporting of randomized controlled trials: a survey of instructions for authors and assessment of trial reports in Indian medical journals (2004-05).
    Tharyan P; Premkumar TS; Mathew V; Barnabas JP; Manuelraj
    Natl Med J India; 2008; 21(2):62-8. PubMed ID: 18807310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of conflict-of-interest disclosure policies of ophthalmology journals.
    Anraku A; Jin YP; Trope GE; Buys YM
    Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing the faults in medical journals.
    Liesegang TJ
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):75-83. PubMed ID: 19333735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advertising in dermatology journals: journals' and journal editors' policies, practices, and attitudes.
    Bartus CL; Katz KA
    J Am Acad Dermatol; 2006 Jul; 55(1):116-22. PubMed ID: 16781302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential publication of editorial board members in medical specialty journals.
    Luty J; Arokiadass SM; Easow JM; Anapreddy JR
    J Med Ethics; 2009 Mar; 35(3):200-2. PubMed ID: 19251974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of Iranian medical journal editors on medical research publication.
    Etemadi A; Raiszadeh F; Alaeddini F; Azizi F
    Saudi Med J; 2004 Jan; 25(1 Suppl):S29-33. PubMed ID: 14968189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of forensic journals, reflections on authorship practices, peer-review and role of the impact factor.
    Jones AW
    Forensic Sci Int; 2007 Jan; 165(2-3):115-28. PubMed ID: 16784827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The medical literature stands to gain from critical appraisal. Commercialism and non-contextualized results under scrutiny].
    Werkö L
    Lakartidningen; 2002 Dec; 99(51-52):5172-5. PubMed ID: 12572312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between funding source and study outcome in orthopaedic research.
    Leopold SS; Warme WJ; Fritz Braunlich E; Shott S
    Clin Orthop Relat Res; 2003 Oct; (415):293-301. PubMed ID: 14612659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals.
    Etter JF; Stapleton J
    J Clin Epidemiol; 2009 Aug; 62(8):831-7. PubMed ID: 19128941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative results and impact factor: a lesson from neonatology.
    Littner Y; Mimouni FB; Dollberg S; Mandel D
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1036-7. PubMed ID: 16275793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.
    Alasbali T; Smith M; Geffen N; Trope GE; Flanagan JG; Jin Y; Buys YM
    Am J Ophthalmol; 2009 Jan; 147(1):33-38.e2. PubMed ID: 18760766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.